Filip Van den Bosch
Overview
Explore the profile of Filip Van den Bosch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
171
Citations
5002
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nash P, Kerschbaumer A, Konzett V, Aletaha D, Dorner T, Fleischmann R, et al.
Ann Rheum Dis
. 2025 Mar;
PMID: 40037995
In light of the introduction of new Janus kinase inhibitors (JAKi), new indications for JAKi and recent safety considerations that have arisen since the preceding consensus statement on JAKi therapy,...
2.
Navarro-Compan V, Van den Bosch F, Sampaio-Barros P, Ostor A, Parikh B, Kato K, et al.
RMD Open
. 2025 Mar;
11(1).
PMID: 40037923
Objectives: Early disease activity control with targeted therapies may improve long-term outcomes in axial spondyloarthritis (axSpA). Here, we evaluated the efficacy of upadacitinib in patients with axSpA with shorter versus...
3.
Poddubnyy D, Navarro-Compan V, Torgutalp M, Arends S, Aydin S, Battista S, et al.
Ann Rheum Dis
. 2025 Feb;
PMID: 39955166
Objectives: To develop a consensus-based expert definition of difficult-to-manage (D2M) axial spondyloarthritis (axSpA), incorporating treatment-refractory (TR) disease. Methods: A literature review was conducted in 2022 to identify potential definitions for...
4.
Van den Bosch F, Deodhar A, Poddubnyy D, Maksymowych W, van der Heijde D, Kim T, et al.
Arthritis Res Ther
. 2025 Feb;
27(1):23.
PMID: 39905436
Background: In SELECT-AXIS 2, upadacitinib improved the signs and symptoms of active non-radiographic axial spondyloarthritis (nr-axSpA) through 52 weeks versus placebo and was well tolerated. Here, we evaluated the efficacy...
5.
Perez-Alamino R, Maldonado-Ficco H, Molto A, Waimann C, Maldonado-Cocco J, Dougados M, et al.
RMD Open
. 2025 Jan;
11(1).
PMID: 39890204
Background: Diagnostic delay is one of the greatest challenges in spondyloarthritis (SpA). Better disease knowledge and more accessibility to new image technology could have a positive impact on time to...
6.
Mayer A, Brandon T, Aggarwal A, Burgos-Vargas R, Colbert R, Horneff G, et al.
J Rheumatol
. 2025 Jan;
52(2):165-172.
PMID: 39814440
Objective: To evaluate the influence of pelvic magnetic resonance imaging (MRI) findings on axial disease assessment in juvenile spondyloarthritis (JSpA). Methods: This was a cross-sectional study of patients with JSpA...
7.
Baraliakos X, Deodhar A, van der Heijde D, Van den Bosch F, Magrey M, Maksymowych W, et al.
Rheumatology (Oxford)
. 2025 Jan;
PMID: 39798135
Objectives: Bimekizumab, a monoclonal IgG1 antibody that selectively inhibits interleukin (IL)‑17F in addition to IL-17A, previously demonstrated efficacy and was well tolerated to 1 year in patients with non-radiographic (nr-)...
8.
Weiss P, Brandon T, Aggarwal A, Burgos-Vargas R, Colbert R, Horneff G, et al.
Arthritis Care Res (Hoboken)
. 2024 Dec;
PMID: 39721765
Objective: The Paediatric Rheumatology International Trials Organisation (PRINTO) recently undertook an effort to better harmonize the pediatric and adult arthritis criteria. These provisional criteria are being refined for optimal performance....
9.
Venken K, Jarlborg M, Stevenaert F, Malfait T, Vlieghe C, Abraham Y, et al.
Ann Rheum Dis
. 2024 Nov;
PMID: 39521450
Objectives: Smoking has been associated with an increased risk of developing rheumatoid arthritis (RA) in individuals carrying shared epitope (SE) HLA-DRB1 alleles. Yet, little is known about the regional and...
10.
Maldonado-Ficco H, Lopez-Medina C, Perez-Alamino R, Waimann C, Maldonado-Cocco J, Molto A, et al.
Rheumatology (Oxford)
. 2024 Oct;
PMID: 39361425
Objectives: Uveitis is a common extra-musculoskeletal manifestation in Spondyloarthritis (SpA). The aim of this study was to analyze the prevalence of uveitis in SpA patients, its association with geographical areas...